DK172686A - Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet - Google Patents

Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet Download PDF

Info

Publication number
DK172686A
DK172686A DK172686A DK172686A DK172686A DK 172686 A DK172686 A DK 172686A DK 172686 A DK172686 A DK 172686A DK 172686 A DK172686 A DK 172686A DK 172686 A DK172686 A DK 172686A
Authority
DK
Denmark
Prior art keywords
cancer
procedure
antigen
diagnosis
detection
Prior art date
Application number
DK172686A
Other languages
English (en)
Other versions
DK172686D0 (da
Inventor
Karen Burnett
Esther Oh
Julia Leung
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Publication of DK172686D0 publication Critical patent/DK172686D0/da
Publication of DK172686A publication Critical patent/DK172686A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1063—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from stomach or intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK172686A 1985-04-22 1986-04-16 Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet DK172686A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72620185A 1985-04-22 1985-04-22

Publications (2)

Publication Number Publication Date
DK172686D0 DK172686D0 (da) 1986-04-16
DK172686A true DK172686A (da) 1986-10-23

Family

ID=24917619

Family Applications (1)

Application Number Title Priority Date Filing Date
DK172686A DK172686A (da) 1985-04-22 1986-04-16 Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet

Country Status (7)

Country Link
EP (1) EP0199586A3 (da)
JP (1) JPS61282096A (da)
AU (1) AU5637086A (da)
DK (1) DK172686A (da)
ES (1) ES8800603A1 (da)
FI (1) FI861691A7 (da)
NO (1) NO861491L (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521285A (en) * 1984-01-31 1996-05-28 Akzo Nobel N.V. CTAA 28A32, the antigen recognized by MCA 28A32
US4693975A (en) * 1984-11-20 1987-09-15 The Wistar Institute Human hybridroma fusion partner for production of human monoclonal antibodies
ES8800604A1 (es) * 1985-04-22 1987-11-16 Hybritech Inc Un metodo para producir anticuerpos monoclonales
JP2519038B2 (ja) * 1986-07-29 1996-07-31 郁男 山科 単クロ―ン抗体及びその製造方法
JPH0661276B2 (ja) * 1987-02-24 1994-08-17 ポ−ラ化成工業株式会社 腫瘍関連抗原に特異的な抗体およびこれを利用する抗原の測定法
DK169987D0 (da) * 1987-04-03 1987-04-03 Jens Christian Jensenius Human tumor-associated antigen, ca-ou1
JP2688824B2 (ja) * 1987-05-29 1997-12-10 郁男 山科 単クローン抗体ｎｋｙ１３
US5073493A (en) * 1987-05-29 1991-12-17 Ikuo Yamashina Monoclonal antibody nky13
EP0397419A3 (en) * 1989-05-10 1991-04-03 Hybritech Incorporated Novel tumor-associated antigen, antibodies, compositions and uses therefor
ES2090331T3 (es) * 1990-04-12 1996-10-16 Akzo Nobel Nv Ctaa 28a32, antigeno reconocido por mca 28a32.
IT1262954B (it) * 1992-07-03 1996-07-23 Ist Farmacoterapico It Spa Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.
IT1276860B1 (it) * 1994-11-04 1997-11-03 Zetesis Spa Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione
SE9500148D0 (sv) * 1995-01-18 1995-01-18 Bioinvent Internatioal Ab Antibodies for use in cancer therapy and diagnosis
US20050027106A1 (en) * 2003-07-28 2005-02-03 Young David S. F. Cancerous disease modifying antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468457A (en) * 1981-06-01 1984-08-28 David M. Goldenberg Method for producing a CSAp tryptic peptide and anti-CSAp antibodies

Also Published As

Publication number Publication date
ES8800603A1 (es) 1987-11-16
EP0199586A3 (en) 1988-05-04
AU5637086A (en) 1986-10-30
FI861691L (fi) 1986-10-23
NO861491L (no) 1986-10-23
JPS61282096A (ja) 1986-12-12
DK172686D0 (da) 1986-04-16
FI861691A7 (fi) 1986-10-23
EP0199586A2 (en) 1986-10-29
FI861691A0 (fi) 1986-04-22
ES554206A0 (es) 1987-11-16

Similar Documents

Publication Publication Date Title
DE3586440D1 (de) Zur diagnose von menschlichem magen- oder brustkrebs zu verwendender monoklonaler antikoerper.
AR229053A1 (es) Aparato de examen medico
DK172686A (da) Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet
FI872756A0 (fi) Med laserstraolning fungerande terapeutisk anordning.
IT7924560A0 (it) Procedimento e dispositivo per analisi di campioni di sangue intero.
DK101890A (da) Monoklonale antistoffer mod human interleukin-4 og hybridomaer, der producerer saadanne
DE59705683D1 (de) IMMUNOLOGISCHES NACHWEISVERFAHREN VON ANTIKÖRPERN, DIE GEGEN GEWEBE-TRANSGLUTAMINASE (tTG) GERICHTET SIND, VERWENDUNG VON tTG ZUR DIAGNOSE UND THERAPIEKONTROLLE SOWIE ORALES PHARMAZEUTISCHES MITTEL ENTHALTEND tTG
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
ES245584Y (es) Canula mejorada para la toma o extraccion de sangre
DK162531C (da) Monoklonalt antistof, fremgangsmaade til fremstilling deraf og diagnostisk udstyr egnet til detektering og diagnosticering af human ikke-smaacellet lungecancer under anvendelse af det monoklonale antistof
IT1197431B (it) Antigene anti-malarico, procedimento per la sua preparazione e vaccino che lo contiene
FI912050A0 (fi) Menetelmä ihmisen papilloomaviruksen (HPV) toteamiseksi diagnostista käyttöä varten
NO830570L (no) Antistoffer og antigener for diagnose og behandling av cancer
JPS54126596A (en) Method of detecting or fixing virus antigen or red blood* bacteria antigen or antigen
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
DE3771304D1 (de) Geraet zur tomographie mittels gamma-strahlung.
DK355483A (da) Monoklonale antistoffer til krydsafstemning af humant vaev
IL61641A (en) Human cancer cell associated antigens,their preparation and purification,a diagnostic kit comprising antibodies thereto and its use for immunological detection of cancer
DK360186A (da) Diagnostisk fremgangsmaade til bedoemmelse af kliniske parametre ved direkte samling af biologiske materialer, og organ til udfoerelse af fremgangsmaaden
DK331688A (da) Apparat til undersoegelse af leverfunktionen
FI873606A7 (fi) Ihmisen glykoalbumiinin määrittämiseen käyttökelpoisia vasta-aineita.
FR2608767B1 (fr) Procede pour la detection et le dosage des anticorps anti-(sporozoaires de p. falciparum) dans le sang humain et trousses de diagnostic pour mettre en oeuvre ce procede
NO883626D0 (no) Fremgangsmaate for diagnose av kikhoste og testsett for utfoerelse av fremgangsmaaten.
IT8025201A0 (it) Procedimento e dispositivo per raccogliere campioni di sangue.
EP0119259A4 (en) Non a, non b hepatitis virus, methods of identification, purification, characterization, diagnosis and immunization.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
B1 Patent granted (law 1993)